Jenny Murase is a Dermatology physician affiliated with University of California, San Francisco. OpenAlex indexes 171 publications with 2,905 citations (h-index 30).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
701 E El Camino Real
Mountain View, CA 940402833
Telephone
650-934-7676Registry record last updated 9 Jan 2012.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Galderma Laboratories, L.P.Program year2025136 payments$150,599openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year202555 payments$94,537openpaymentsdata.cms.gov ↗
- Regeneron Healthcare Solutions, Inc.Program year202584 payments$91,524openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
31%Interleukin-4 Receptor alpha Antagonist17.3%Dupixent Syringe73%Dupixent Pen27%Part D<11 patientsCorticosteroid8.8%Triamcinolone Acetonide71%Triamcinolone acetonide29%Part D + Part B≥39 patients+ 3 more classes in this area
Nervous system
12.8%Antihistamine5.9%Hydroxyzine Hcl100%Part D≥27 patientsGabapentinoids5.7%Gabapentin56%Pregabalin44%Part D≥13 patients+ 1 more class in this area
Sensory organs
12.5%Corticosteroid12.5%Clobetasol Propionate63%Desonide19%Hydrocortisone18%Part D≥51 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety of dermatologic medications in pregnancy and lactation: An update - Part I: Pregnancy
Journal of the American Academy of Dermatology
2024 - Safety of dermatologic medications in pregnancy and lactation: An update—Part II: Lactation
Journal of the American Academy of Dermatology
2024 - Assessment of skin of color and diversity and inclusion content of dermatologic published literature: An analysis and call to action
International Journal of Women’s Dermatology
2021 - The impact of gender in mentor–mentee success: Results from the Women's Dermatologic Society Mentorship Survey
International Journal of Women’s Dermatology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”